These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27889655)

  • 1. A Prediction Model Based on Biomarkers and Clinical Characteristics for Detection of Lung Cancer in Pulmonary Nodules.
    Ma J; Guarnera MA; Zhou W; Fang H; Jiang F
    Transl Oncol; 2017 Feb; 10(1):40-45. PubMed ID: 27889655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules.
    Lin Y; Leng Q; Jiang Z; Guarnera MA; Zhou Y; Chen X; Wang H; Zhou W; Cai L; Fang H; Li J; Jin H; Wang L; Yi S; Lu W; Evers D; Fowle CB; Su Y; Jiang F
    Int J Cancer; 2017 Sep; 141(6):1240-1248. PubMed ID: 28580707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer.
    Su J; Leng Q; Lin Y; Ma J; Jiang F; Lee CJ; Fang H; Jiang F
    Biomark Cancer; 2018; 10():1179299X18759297. PubMed ID: 29467585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
    Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
    Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Low-Dose CT-Based Radiomic Model to Improve Characterization and Screening Recall Intervals of Indeterminate Prevalent Pulmonary Nodules.
    Rundo L; Ledda RE; di Noia C; Sala E; Mauri G; Milanese G; Sverzellati N; Apolone G; Gilardi MC; Messa MC; Castiglioni I; Pastorino U
    Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34573951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prediction model based on computed tomography characteristics for identifying malignant from benign sub-centimeter solid pulmonary nodules.
    Cui SL; Qi LL; Liu JN; Li FL; Chen JQ; Cheng SN; Xu Q; Wang JW
    J Thorac Dis; 2024 Jul; 16(7):4238-4249. PubMed ID: 39144338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with overdiagnosis of benign pulmonary nodules as malignancy: a retrospective cohort study.
    Duan X; Ouyang Z; Bao S; Yang L; Deng A; Zheng G; Zhu Y; Li G; Chu J; Liao C
    BMC Pulm Med; 2023 Nov; 23(1):454. PubMed ID: 37990211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer.
    Zhang J; Yao H; Lai C; Sun X; Yang X; Li S; Guo Y; Luo J; Wen Z; Tang K
    Chin J Cancer Res; 2023 Oct; 35(5):511-525. PubMed ID: 37969955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
    Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application effect of low-dose spiral CT on pulmonary nodules and its diagnostic value for benign and malignant nodules.
    Zheng C; Wang H; Liu Q; Han D; Xin Y; Lu W; Yan Z
    Am J Transl Res; 2023; 15(1):256-263. PubMed ID: 36777849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Plasma miRNAs and Computed Tomography Features to Differentiate the Nature of Pulmonary Nodules.
    Xi K; Wang W; Wen Y; Chen Y; Zhang X; Wu Y; Zhang R; Wang G; Huang Z; Zhang L
    Front Oncol; 2019; 9():975. PubMed ID: 31632908
    [No Abstract]   [Full Text] [Related]  

  • 13. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary pulmonary nodules: clinical prediction model versus physicians.
    Swensen SJ; Silverstein MD; Edell ES; Trastek VF; Aughenbaugh GL; Ilstrup DM; Schleck CD
    Mayo Clin Proc; 1999 Apr; 74(4):319-29. PubMed ID: 10221459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy.
    Ye M; Tong L; Zheng X; Wang H; Zhou H; Zhu X; Zhou C; Zhao P; Wang Y; Wang Q; Bai L; Cai Z; Kong FS; Wang Y; Li Y; Feng M; Ye X; Yang D; Liu Z; Zhang Q; Wang Z; Han S; Sun L; Zhao N; Yu Z; Zhang J; Zhang X; Katz RL; Sun J; Bai C
    Front Oncol; 2022; 12():853801. PubMed ID: 35311112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.
    Swensen SJ; Silverstein MD; Ilstrup DM; Schleck CD; Edell ES
    Arch Intern Med; 1997 Apr; 157(8):849-55. PubMed ID: 9129544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-aided diagnostic scheme for distinction between benign and malignant nodules in thoracic low-dose CT by use of massive training artificial neural network.
    Suzuki K; Li F; Sone S; Doi K
    IEEE Trans Med Imaging; 2005 Sep; 24(9):1138-50. PubMed ID: 16156352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy.
    Reid M; Choi HK; Han X; Wang X; Mukhopadhyay S; Kou L; Ahmad U; Wang X; Mazzone PJ
    Chest; 2019 Aug; 156(2):367-375. PubMed ID: 30940455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.